Liver Neoplasms: all 1,406 studies
Page 14 of 15. Open to participants first (347), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver MetastasesCompletedNCT00242086Not applicable
- Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00238394Phase 2
- Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver CancerWithdrawnNCT00238160Phase 3
- Qidong Hepatitis B Intervention StudyCompletedNCT00222664Phase 4
- Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or CholangiocarcinomaTerminatedNCT00216437Phase 1
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal CancerCompletedNCT00200200Phase 2
- Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver OnlyCompletedNCT00199173Phase 3
- A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the LiverCompletedNCT00191412Phase 2
- Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
- Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver MetastasesTerminatedNCT00185874Phase 1
- Quality of Life and Liver MetastasesCompletedNCT00184834
- Feasibility of Treatment of Cancer Involving the Liver With High Dose RadiationCompletedNCT00178243Phase 1/2
- Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal AdenocarcinomaCompletedNCT00168155Phase 2
- Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver MetastasesStatus unknownNCT00156975Phase 3
- Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)CompletedNCT00153998Phase 2
- Stereotactic Radiotherapy (SRT) Liver (COLD 1)CompletedNCT00152906Phase 1/2
- Orthotopic Liver Transplantation Using a Living DonorTerminatedNCT00152607Phase 4
- A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.Status unknownNCT00152087Phase 2
- Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerTerminatedNCT00151671Phase 2/3
- The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver MetastasesTerminatedNCT00145665Phase 1/2
- Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00128596Phase 2
- Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedNCT00122876Phase 1/2
- Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00109954Phase 3
- Neoadjuvant Colorectal Cancer With Unresectable Liver MetastasesTerminatedNCT00106054Phase 2
- Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerCompletedNCT00096083Phase 2
- SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver CancerCompletedNCT00095992Phase 2
- Study of NS-9 in Patients With Liver MetastasesCompletedNCT00094003Phase 1
- Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver CancerWithdrawnNCT00093548Phase 1/2
- Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver TumorsCompletedNCT00093444Phase 1
- Irinotecan and Flavopiridol in Treating Patients With Advanced Liver CancerCompletedNCT00087282Phase 2
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver MetastasesCompletedNCT00083785Phase 2
- Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid TumorsCompletedNCT00081848Phase 1
- Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerCompletedNCT00081094Not applicable
- Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)Status unknownNCT00079027Phase 3
- Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077441Phase 2
- Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaStatus unknownNCT00077389Phase 2
- TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077142Phase 1/2
- Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular CarcinomaCompletedNCT00076609Phase 1/2
- Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2
- Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00071994Phase 2
- Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver MetastasesCompletedNCT00068068Phase 2
- Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00059865Phase 1/2
- Epirubicin and Thalidomide in Treating Patients With Liver CancerCompletedNCT00058487Phase 2
- Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNCT00057980Phase 1/2
- T900607 in Treating Patients With Unresectable Liver CancerCompletedNCT00054262Phase 2
- Oxaliplatin in Treating Patients With Liver CancerCompletedNCT00052364Phase 2
- Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular CarcinomaTerminatedNCT00051545Phase 3
- Seocalcitol Versus Placebo in Advanced Hepatocellular CarcinomaTerminatedNCT00051532Not applicable
- Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver DysfunctionCompletedNCT00047346Phase 1
- Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically RemovedTerminatedNCT00047333Phase 2
- Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00047229Phase 2
- Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
- Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00041275Phase 3
- Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically RemovedCompletedNCT00040898Phase 2
- Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by SurgeryWithdrawnNCT00039078Phase 2
- ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 1
- Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerCompletedNCT00033462Phase 2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct CancerTerminatedNCT00030511Phase 2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
- Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver CancerCompletedNCT00030082Phase 1
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
- Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver CancerStatus unknownNCT00027768Phase 3
- Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerCompletedNCT00027534Phase 1
- BMS-247550 in Treating Patients With Liver or Gallbladder CancerTerminatedNCT00023946Phase 2
- Vaccine Therapy in Treating Patients With Liver CancerCompletedNCT00022334Phase 1/2
- Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
- SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver CancerWithdrawnNCT00020774Phase 2
- Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
- Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesCompletedNCT00019786Phase 2
- Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
- Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerCompletedNCT00019474Phase 2
- Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
- Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver CancerCompletedNCT00012324Phase 3
- Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00009893Phase 2
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
- Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular CancerStatus unknownNCT00006198Phase 2
- Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00006016Phase 2
- Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver CancerCompletedNCT00006010Phase 2
- Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically RemovedCompletedNCT00006006Phase 2
- Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary CancerTerminatedNCT00005997Phase 2
- Vaccine Therapy in Treating Patients With Liver CancerCompletedNCT00005629Phase 1/2
- Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00004248Phase 2
- Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver CancerCompletedNCT00004136Phase 2
- DX-8951f in Treating Patients With Liver CancerCompletedNCT00004108Phase 2
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver CancerCompletedNCT00003994Phase 3
- Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsTerminatedNCT00003926Phase 1
- Chemotherapy in Treating Children With Liver CancerCompletedNCT00003912Phase 3
- Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney CancerWithdrawnNCT00003714Phase 2
- Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder CancerCompletedNCT00003557Phase 2
- Antineoplaston Therapy in Treating Patients With Primary Liver CancerTerminatedNCT00003530Phase 2
- Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
- Tamoxifen in Treating Patients With Primary Liver CancerCompletedNCT00003424Phase 3
- Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct CancerStatus unknownNCT00003296Phase 2
- Gene Therapy in Treating Patients With Cancer of The LiverTerminatedNCT00003147Phase 1
- Chemotherapy in Treating Patients With Liver CancerStatus unknownNCT00003044Phase 2